Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Athenex, inc.    crawled time : 14:03    save search

Athenex Presents Updated Phase 3 Data on Survival and Tolerability Associated with Oral Paclitaxel and Encequidar in Patients with Metastatic Breast Cancer
Published: 2020-12-09 (Crawled : 14:03) - globenewswire.com
ATNX | $0.2031 -7.78% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: 1.59% H: 1.57% C: -4.86%

breast cancer cancer phase 3 metastatic breast cancer
Gainers vs Losers
74% 26%

Top 10 Gainers
AGBA | News | $1.27 217.5% 120M twitter stocktwits trandingview |
Finance

EGOX | $0.054 50.0% 290M twitter stocktwits trandingview |

INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals

NVFY | $2.71 28.44% 31M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.86 28.28% 29M twitter stocktwits trandingview |
Commercial Services

BSFC | $0.0822 27.64% 75M twitter stocktwits trandingview |
Manufacturing

RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a

CHRO | $1.53 24.9% 100K twitter stocktwits trandingview |
n/a

HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals

INSG | $2.98 23.14% 190K twitter stocktwits trandingview |
Electronic Technology


Your saved searches
Save your searches and get alerts when important news are released.